Summary
Horizon Discovery Group plc (Horizon Discovery) is a genomics company that develops and supplies patient-relevant drug discovery and diagnostic products. The company provides rAAV, ZFN and CRISPR custom cell line and in vivo model generation services for research and bioproduction applications. It offers quantitative molecular reference standards, in vivo disease models, custom screening services for target identification and validation, and drug combination studies. Horizon Discovery’s research services comprise immuno oncology platform, functional genomic screening, drug combination screening, and in vitro assay and in vivo services. The company operates in Austria, the UK and the US. Horizon Discovery is headquartered in Cambridge, the UK.
Horizon Discovery Group Plc (HZD) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Horizon Discovery Group Plc, Medical Equipment, Deal Details 12
Asset Purchase 12
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 12
Partnerships 13
Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13
Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14
Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15
Horizon Discovery Enters Into Licensing Agreement With ATCC 16
Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17
Sophia Genetics Enters into Agreement with Horizon Discovery Group 18
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 19
Agena Bioscience Enters into Agreement with Horizon Discovery 20
CareDx Enters into Co-Development Agreement with Horizon Discovery 21
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 22
Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 23
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 24
Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 25
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 26
Horizon Discovery Enters Into Co-Development Agreement With Promega 27
Horizon Discovery Enters Into Co-Development Agreement With University Of Washington 28
Equity Offering 29
Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29
Horizon Discovery Group Plc - Key Competitors 30
Horizon Discovery Group Plc - Key Employees 31
Horizon Discovery Group Plc - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 32
Recent Developments 34
Product News 34
Sep 25, 2017: Horizon Discovery introduces OncoSpan, the world’s largest DNA multiplex Reference Standard for oncology 34
Feb 20, 2017: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma 35
Apr 15, 2016: Horizon Discovery Introduces High Throughput Platform for Immuno-Oncology Research 36
Mar 22, 2016: Horizon Discovery Group Launches HDx RNA Fusion Reference Standards 37
Jan 12, 2016: ArcherDX Launches SureShot Triple Fusion-Positive NGS Control 38
Other Significant Developments 39
Nov 17, 2016: Horizon Discovery Partners with Sophia Genetics on NGS Reference Standards for Oncology Applications 39
Jun 01, 2016: Horizon Discovery Group’s Molecular Reference Standards integrated into QIAGEN GeneReader NGS System 40
May 12, 2016: Horizon Enters into OEM Agreements with Market Leading Next Generation Sequencing Company 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Horizon Discovery Group Plc, Medical Equipment, Key Facts, 2016 2
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Horizon Discovery Group Plc, Deals By Market, 2011 to YTD 2017 9
Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 12
Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13
Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14
Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15
Horizon Discovery Enters Into Licensing Agreement With ATCC 16
Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17
Sophia Genetics Enters into Agreement with Horizon Discovery Group 18
Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 19
Agena Bioscience Enters into Agreement with Horizon Discovery 20
CareDx Enters into Co-Development Agreement with Horizon Discovery 21
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 22
Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 23
Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 24
Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 25
Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 26
Horizon Discovery Enters Into Co-Development Agreement With Promega 27
Horizon Discovery Enters Into Co-Development Agreement With University Of Washington 28
Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29
Horizon Discovery Group Plc, Key Competitors 30
Horizon Discovery Group Plc, Key Employees 31
Horizon Discovery Group Plc, Subsidiaries 32
Horizon Discovery Group Plc, Joint Venture 32
